Delivery Order SPE2DB24D1205-SPE2DB25FDALB
- Not listed
- The Defense Logistics Agency awarded a $1,309.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Nayzilam 5 mg nasal sprays. The contract, which is non-set-aside and competitively awarded, is set for completion by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,218.76 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays. This competitively awarded, firm fixed-price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,391.00 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray. This firm fixed price contract, awarded on August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside designation and will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,965.52 to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays. This firm fixed-price, competitively awarded contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nayzilam 5 mg nasal sprays with a contract ceiling value of $1,987.32. This firm fixed-price delivery order, which is non-competitive and set-aside-free, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $3,477.50 delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays under a firm fixed price contract structure. The award was issued on July 28, 2025, with a completion date of July 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is executed as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.60 to AmerisourceBergen Drug Corp for NAYZILAM 5 MG nasal sprays under a firm fixed price contract type. This delivery order, issued on August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not set-aside and was competitively awarded, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.25 to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. This delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDALBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $1,100 in Nayzilam 5 mg nasal sprays. This non-set-aside, competitively awarded contract employs firm fixed pricing and maintains a completion deadline of September 15, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare programs. AmerisourceBergen Drug Corp functions as a critical vendor in the federal medical procurement supply chain, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company demonstrates extensive capability in delivering a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for Nayzilam—an intranasal benzodiazepine used for acute seizure management—exemplifies the company's role in supplying specialized pharmaceutical commodities essential to military medical operations and veterans' healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/12/25 |